Judd W. Moul

27.8k total citations · 2 hit papers
526 papers, 20.5k citations indexed

About

Judd W. Moul is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Judd W. Moul has authored 526 papers receiving a total of 20.5k indexed citations (citations by other indexed papers that have themselves been cited), including 417 papers in Pulmonary and Respiratory Medicine, 121 papers in Surgery and 87 papers in Oncology. Recurrent topics in Judd W. Moul's work include Prostate Cancer Treatment and Research (335 papers), Prostate Cancer Diagnosis and Treatment (332 papers) and Urologic and reproductive health conditions (75 papers). Judd W. Moul is often cited by papers focused on Prostate Cancer Treatment and Research (335 papers), Prostate Cancer Diagnosis and Treatment (332 papers) and Urologic and reproductive health conditions (75 papers). Judd W. Moul collaborates with scholars based in United States, Germany and United Kingdom. Judd W. Moul's co-authors include David G. McLeod, Leon Sun, Isabell A. Sesterhenn, Shiv Srivastava, Peter R. Carroll, John J. Bauer, Thomas J. Polascik, Anthony V. D’Amico, Roger R. Connelly and Ming‐Hui Chen and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Judd W. Moul

510 papers receiving 19.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update

2007 864 citations Ian M. Thompson, Jeffrey D. Forman et al. The Journal of Urology profile →
Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes

2007 631 citations Jeffrey D. Forman, Judd W. Moul et al. The Journal of Urology profile →

Peers

Countries citing papers authored by Judd W. Moul

Since Specialization

Citations

This map shows the geographic impact of Judd W. Moul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judd W. Moul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judd W. Moul more than expected).

Fields of papers citing papers by Judd W. Moul

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judd W. Moul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judd W. Moul. The network helps show where Judd W. Moul may publish in the future.

Co-authorship network of co-authors of Judd W. Moul

This figure shows the co-authorship network connecting the top 25 collaborators of Judd W. Moul. A scholar is included among the top collaborators of Judd W. Moul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judd W. Moul. Judd W. Moul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification 2023 ·Prostate Cancer and Prostatic Diseases ·Neal D. Shore, Judd W. Moul, Kenneth J. Pienta, Johannes Czernin, Martin T. King, Stephen J. Freedland	53
2	Urinary microbiota and prostatic diseases: the key for the lock? A systematic review 2022 ·Prostate Cancer and Prostatic Diseases ·Georges Mjaess, (unknown), Thierry Roumeguère, (unknown), Fouad Aoun, Kevin T. McVary, Judd W. Moul, Cosimo De Nunzio, Simone Albisinni	14
3	Initial Longitudinal Outcomes of Risk-Stratified Men in Their Forties Screened for Prostate Cancer Following Implementation of a Baseline Prostate-Specific Antigen 2022 ·The World Journal of Men s Health ·(unknown), Srinath Kotamarti, (unknown), (unknown), Anand Shah, John Anderson, Andrew J. Armstrong, Rajan T. Gupta, Steven R. Patierno, Nadine J. Barrett, Daniel J. George, Glenn M. Preminger, Judd W. Moul, Kevin C. Oeffinger, (unknown), (unknown)	1
4	A Randomized Controlled Trial of a 6-Month Low-Carbohydrate Intervention on Disease Progression in Men with Recurrent Prostate Cancer: Carbohydrate and Prostate Study 2 (CAPS2) 2020 ·Clinical Cancer Research ·Stephen J. Freedland, (unknown), (unknown), Taofik Oyekunle, Andrew J. Armstrong, Judd W. Moul, Howard M. Sandler, Edwin M. Posadas, (unknown), (unknown), Lauren E. Howard, Yuan Wu, Pao‐Hwa Lin	40
5	A protocol to reduce self-reported pain scores and adverse events following lumbar punctures in older adults 2020 ·Journal of Neurology ·(unknown), Chloe K. Nobuhara, W. Michael Bullock, (unknown), (unknown), Mary Cooter, Michael J. Devinney, Michael N. Ferrandino, Jeff Gadsden, Grant E. Garrigues, Ashraf S. Habib, Eugene Moretti, Judd W. Moul, (unknown), (unknown), Randall P. Scheri, (unknown), Jake Thomas, (unknown), Joseph P. Mathew, Miles Berger	9
6	Conservative Management of a Pyelovenous Fistula After a Renal Gunshot Wound 2019 ·Journal of Endourology Case Reports ·Michael Stern, Neel Patel, Brian M. Inouye, Ghalib Jibara, Judd W. Moul, Ariel Schulman	1
7	Postoperative Radiation Therapy for Pathologically Advanced Prostate Cancer After Radical Prostatectomy 2011 ·European Urology ·Andrew J. Stephenson, M. Bolla, Alberto Briganti, C. Cozzarini, Judd W. Moul, Mack Roach, Hendrik Van Poppel, Anthony L. Zietman	85
8	Impact of Primary Gleason Grade on Risk Stratification for Gleason Score 7 Prostate Cancers 2011 ·International Journal of Radiation OncologyBiologyPhysics ·Bridget F. Koontz, Matvey Tsivian, Vladimir Mouraviev, Leon Sun, Željko Vujašković, Judd W. Moul, W. Robert Lee	17
9	Lidocaine Patch for Postoperative Analgesia After Radical Retropubic Prostatectomy 2009 ·Anesthesia & Analgesia ·Ashraf S. Habib, Thomas J. Polascik, Alon Z. Weizer, William D. White, Judd W. Moul, (unknown), Tong J. Gan	38
10	POD-05.09: Predicting Unilaterality of Prostate Cancer on Biopsy: Sextant Versus Extended 2009 ·Urology ·(unknown), Masaki Kimura, Leon Sun, Vladimir Mouraviev, Janice M. Mayes, Judd W. Moul, Thomas J. Polascik	2
11	SIOG (INTERNATIONAL SOCIETY OF GERIATRIC ONCOLOGY) 2008 ·European Urology Supplements ·Steven Joniau, Lodovico Balducci, M. Bolla, Mark Emberton, Patricia Fitzpatrick, Michael W. Kattan, S. Monfardini, Judd W. Moul, Arash Naeim, Hendrik Van Poppel, Fred Saad, C. Sternberg, J.P. Droz	1
12	Pentosan polysulfate decreases prostate smooth muscle proliferation and extracellular matrix turnover 2003 ·Prostate Cancer and Prostatic Diseases ·Sharon J. Elliot, (unknown), D. G. McLeod, Judd W. Moul, Leroy M. Nyberg, Liliane J. Striker, (unknown)	7
13	Effect of age on biochemical disease-free outcome in patients with T1-T3 prostate cancer treated with definitive radiotherapy in an equal-access health care system 2003 ·International Journal of Radiation OncologyBiologyPhysics ·Peter A.S. Johnstone, Robert H. Riffenburgh, Judd W. Moul, Leon Sun, Hongyu Wu, David G. McLeod, Christopher J. Kane, Douglas Martin, Leo Kusuda, Raymond Lance, Robert G. Douglas, Timothy F. Donahue, (unknown), (unknown), Andrew Chung, Douglas W. Soderdahl, (unknown), Christopher L. Amling	25
14	Clinical staging of prostate cancer: Reproducibility and clarification of issues 2001 ·International Journal of Cancer ·Timothy Campbell, John C. Blasko, E. David Crawford, Jeffrey D. Forman, Gerald E. Hanks, Deborah A. Kuban, James E. Montie, Judd W. Moul, Alan Pollack, Derek Raghavan, Paul S. Ray, Mack Roach, Gary D. Steinberg, Nelson N. Stone, Ian M. Thompson, Nicholas J. Vogelzang, Srinivasan Vijayakumar	19
15	Prostate Biopsy Protocols: 3D Visualization-Based Evaluation and Clinical Correlation 2001 ·Computer Aided Surgery ·Jianchao Zeng, John J. Bauer, Wei Zhang, Isabell A. Sesterhenn, Roger R. Connelly, John H. Lynch, Judd W. Moul, Seong K. Mun	9
16	Changing face and different countenances of prostate cancer: Racial and geographic differences in prostate‐specific antigen (PSA), stage, and grade trends in the PSA era 2001 ·International Journal of Cancer ·Ashesh B. Jani, Florin Vaida, Gerald E. Hanks, (unknown), Oliver Sartor, Judd W. Moul, Mack Roach, David Brachman, (unknown), (unknown), Paul S. Ray, Lani Ignacio, A. Awan, Ralph R. Weichselbaum, Srinivasan Vijayakumar	46
17	Benign Prostatic Hyperplasia: New Concepts for the Millennium 1999 ·The American Journal of Managed Care ·(unknown), John J. Bauer, Judd W. Moul	1
18	Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancer 1996 ·Surgery ·Judd W. Moul, Marie‐Claude Bettencourt, Isabell A. Sesterhenn, F.K. Mostofi, David G. McLeod, Shiv Srivastava, John J. Bauer	108
19	1992 New York-Tidewater chapters History of Military Medicine Essay Award recipient. James Claude Kimbrough: the father of modern U.S. Army urology. 1993 ·PubMed ·Judd W. Moul	1
20	Expression of the c-erbB-2 (Her-2/neu) Oncoprotein in Human Prostatic Carcinoma 1993 ·The Journal of Urology ·(unknown), (unknown), Isabell A. Sesterhenn, Esther H. Chang, Judd W. Moul	127

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact